-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Jan 30, 16:00Prev. Close
42.10
Open Price
42.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
42.20 (2000)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Chandra Bhagat Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 0.55 | 1.17 | 3.09 | 1.97 | |
| Diluted EPS (Rs.) | 0.55 | 1.17 | 3.09 | 1.97 | |
| Cash EPS (Rs.) | 0.46 | 10.11 | 26.14 | 19.23 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 34.05 | 214.34 | 202.00 | 177.27 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 34.05 | 214.34 | 202.00 | 177.27 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 124.56 | 1,585.30 | 2,322.00 | 2,148.00 | |
| PBDIT/Share (Rs.) | 4.66 | 69.71 | 113.63 | 105.13 | |
| PBIT/Share (Rs.) | 4.62 | 68.94 | 112.23 | 101.70 | |
| PBT/Share (Rs.) | 0.56 | 13.21 | 36.67 | 21.84 | |
| Net Profit/Share (Rs.) | 0.42 | 9.34 | 24.73 | 15.80 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 3.73 | 4.39 | 4.89 | 4.89 | |
| PBIT Margin (%) | 3.70 | 4.34 | 4.83 | 4.73 | |
| PBT Margin (%) | 0.44 | 0.83 | 1.57 | 1.01 | |
| Net Profit Margin (%) | 0.33 | 0.58 | 1.06 | 0.73 | |
| Return on Networth / Equity (%) | 1.22 | 4.35 | 12.24 | 8.91 | |
| Return on Capital Employed (%) | 8.56 | 15.26 | 15.94 | 22.71 | |
| Return on Assets (%) | 0.42 | 0.75 | 1.78 | 1.18 | |
| Total Debt/Equity (X) | 1.07 | 1.94 | 2.58 | 2.77 | |
| Asset Turnover Ratio (%) | 125.74 | 128.26 | 167.17 | 160.63 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 2.14 | 1.55 | 1.99 | 1.49 | |
| Quick Ratio (X) | 0.85 | 0.71 | 0.85 | 0.77 | |
| Inventory Turnover Ratio (X) | 2.14 | 2.42 | 2.97 | 3.36 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 57.63 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.61 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 16.40 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.32 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.17 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.32 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.01 | 0.00 | 0.00 | 0.00 |
